Protecting man from health hazards in our industrialized world and contributing to the development of novel therapeutic approaches – these are the aims we pursue at the Fraunhofer Institute for Toxicology and Experimental Medicine ITEM.
A focus is on airway research. A wide range of airborne substances – pollutants but also pharmaceuticals – are taken up via the lungs. In collaboration with our clients from industry and the public sector we develop and test novel medications against respiratory diseases – in particular asthma, allergic rhinitis, and chronic obstructive pulmonary disease (COPD) –, study mechanisms of action, and determine the risks from potentially harmful substances. We thus support product development that keeps an eye on human health and the environment. Due to our highly qualified scientists, many years of experience, and a broad spectrum of expertise, we are in a position to develop innovative approaches in research and offer custom-tailored complete solutions.